L
LogicBio Therapeutics Inc
F:0IF
LogicBio Therapeutics Inc
F:0IF
Price:
2.04
EUR
Market Closed
Market Cap:
€67.2m
Wall Street
Price Targets
0IF Price Targets Summary
LogicBio Therapeutics Inc
LogicBio Therapeutics Inc
Wall Street analysts forecast 0IF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0IF is 3.43 EUR with a low forecast of 3.4 EUR and a high forecast of 3.53 EUR.
Lowest
Price Target
3.4
EUR
67% Upside
Average
Price Target
3.43
EUR
68% Upside
Highest
Price Target
3.53
EUR
73% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0IF's stock price target?
Price Target
3.43
EUR
3.43
EUR
According to Wall Street analysts, the average 1-year price target for 0IF is 3.43 EUR with a low forecast of 3.4 EUR and a high forecast of 3.53 EUR.
What is LogicBio Therapeutics Inc's Revenue forecast?
Projected CAGR
120%
120%
For the last 7 years the compound annual growth rate for LogicBio Therapeutics Inc's revenue is 10%. The projected CAGR for the next 4 years is 120%.
